Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation

References

• Sassano A, Platanias LC. Statins in tumor suppression. Cancer Lett 2008;260:11–19.
   PubMed Web of Science ®Google Scholar
• Khurana V, Caldito G, Ankem M. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. Urology 2008;71:118–122.
   PubMed Web of Science ®Google Scholar
• Khurana V, Bejjanki HR, Caldito G, . Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest 2007;131:1282–1288.
   PubMed Web of Science ®Google Scholar
• Khurana V, Sheth A, Caldito G, . Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans. Pancreas 2007;34:260–265.
   PubMed Web of Science ®Google Scholar
• Woodard J, Sassano A, Hay N, . Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma. Clin Cancer Res 2008;14:4640–4649.
   PubMed Web of Science ®Google Scholar
• Clendening JW, Pandyra A, Boutros PC, . Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci USA 2010;107:15051–15056.
   PubMed Web of Science ®Google Scholar
• Jones KD, Couldwell WT, Hinton DR, . Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 1994;205:1681–1687.
   PubMed Web of Science ®Google Scholar
• Dimitroulakos J, Nohynek D, Backway KL, . Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach. Blood 1999;93:1308–1318.
   PubMed Web of Science ®Google Scholar
• Dimitroulakos J, Ye LY, Benzaquen M, . Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin Cancer Res 2001;7:158–167.
   PubMed Web of Science ®Google Scholar
• Fromigué O, Hamidouche Z, Marie PJ. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. J Pharmacol Exp Ther 2008;325:595–600.
   PubMed Web of Science ®Google Scholar
• Sassano A, Katsoulidis E, Antico G, . Suppressive effects of statins on acute promyelocytic leukemia cells. Cancer Res 2007;67: 4524–4532.
   PubMed Web of Science ®Google Scholar
• Sassano A, Iacono LO, Antico M, . Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Mol Cancer Ther 2009;8:615–625.
   Google Scholar
• Tomiyama N, Matzno S, Kitada C, . The possibility of simvastatin as a chemotherapeutic agent for all-trans retinoic acid-resistant promyelocytic leukemia. Biol Pharm Bull 2008;31:369–374.
   PubMed Web of Science ®Google Scholar
• Reyland ME. Protein kinase C delta and apoptosis. Biochem Soc Trans 2007;35:1001–1004.
   PubMed Web of Science ®Google Scholar
• Redig AJ, Platanias LC. The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis. J Interferon Cytokine Res 2007;27:623–636.
   PubMed Web of Science ®Google Scholar
• Ghayur T, Hugunin M, Talanian RV, . Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399–2404.
   PubMed Web of Science ®Google Scholar
• Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 2002;132: 831–839.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Miki Y, Kufe D. Activation of SAPK/JNK signaling by protein kinase C delta in response to DNA damage. J Biol Chem 2002;277:48372–48378.
   PubMed Web of Science ®Google Scholar
• Ham YM, Choi JS, Chun KH, . The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis. J Biol Chem 2003;278:50330–50337.
   PubMed Web of Science ®Google Scholar
• Yetter A, Uddin S, Krolewski JJ, . Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 1995;270:18179–18182.
   PubMedGoogle Scholar
• Uddin S, Sassano A, Deb DK, . Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002;277:14408–14416.
   PubMed Web of Science ®Google Scholar
• Uddin S, Yenush L, Sun XJ, . Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J Biol Chem 1995;270:15938–15941.
   PubMed Web of Science ®Google Scholar
• Verma A, Mohindru M, Deb DK, . Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide. J Biol Chem 2002;277:44988–44995.
   PubMed Web of Science ®Google Scholar
• Alsayed Y, Uddin S, Mahmud N, . Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 2001;272:4012–4019.
   Web of Science ®Google Scholar
• Kambhampati S, Verma A, Li Y, . Activation of protein kinase C-δ (PKC-δ) by all-trans-retinoic acid. J Biol Chem 2003;278: 32544–32551.
   PubMed Web of Science ®Google Scholar
• Stone RM, Mayer RJ. The unique aspects of APL. J Clin Oncol 1990;8:1913–1921.
   PubMed Web of Science ®Google Scholar
• Fenaux P, Chomienne C. Biology and treatment of APL. Curr Opin Oncol 1996;8:3–12.
   PubMedGoogle Scholar
• Warrell RP Jr, de The H, Wang ZY, . Acute promyelocytic leukemia. N Engl J Med 1993;329:177–189.
   PubMed Web of Science ®Google Scholar
• Borrow J, Goddard AD, Sheer D, . Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990;249:1577–1580.
   PubMed Web of Science ®Google Scholar
• Lin RJ, Sternsdorf T, Tini M, . Transcriptional regulation in APL. Oncogene 2001;20:7204–7215.
   PubMed Web of Science ®Google Scholar
• Scandura JM, Boccuni P, Cammenga J, . Transcription factor fusions in acute leukemia: variations on a theme. Oncogene 2002;21:3422–3444.
   PubMed Web of Science ®Google Scholar
• Kambhampati S, Verma A, Li Y, . Signaling pathways activated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Leuk Lymphoma 2004;45:2175–2185.
   PubMed Web of Science ®Google Scholar
• Coradini D. New chemical strategies for overcoming ATRA resistance in APL cells. Leuk Res 2007;31:291–292.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Nabhan C, Feusner JH, . APL: evolving therapeutic strategies. Blood 2002;99:759–767.
   PubMed Web of Science ®Google Scholar
• Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 2003;17:1454–1463.
   PubMed Web of Science ®Google Scholar
• Douer D, Tallman MS. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 2005;23:2396–2410.
   PubMed Web of Science ®Google Scholar
• Park JH, Tallman MS. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy. Oncology (Williston Park) 2011;25:733–741.
   PubMed Web of Science ®Google Scholar
• Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 2002;16:1940–1958.
   PubMed Web of Science ®Google Scholar
• Goto E, Tomita A, Hayakawa F, . Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment. Blood 2011;118:1600–1609.
   PubMed Web of Science ®Google Scholar
• Xia Z, Tan MM, Wong WW, . Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia 2001;15:1398–1407.
   PubMed Web of Science ®Google Scholar
• Dimitroulakos J, Thai S, Wasfy GH, . Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma 2000;40:167–178.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Banker DE, Stirewalt D, . Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study. Blood 2007;109:2999–3006.
   PubMed Web of Science ®Google Scholar
• Emoto Y, Manome Y, Meinhardt G, . Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 1995;14:6148–6156.
   PubMed Web of Science ®Google Scholar
• Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009;14:2386–2399.
   Google Scholar
• Basu A. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 2003;7:341–350.
   PubMed Web of Science ®Google Scholar
• Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 2003;8:19–27.
   PubMed Web of Science ®Google Scholar
• Gschwendt M. Protein kinase C delta. Eur J Biochem 1999;259: 555–564.
   PubMedGoogle Scholar
• Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 2002;132: 831–839.
   PubMed Web of Science ®Google Scholar
• Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007;7:281–294.
   PubMed Web of Science ®Google Scholar
• Hamdorf M, Berger A, Schüle S, . PKCδ-induced PU.1 phosphorylation promotes hematopoietic stem cell differentiation to dendritic cells. Stem Cells 2011;29:297–306.
   PubMed Web of Science ®Google Scholar
• Higai K, Satake M, Nishioka H, et al K. Glycated human serum albumin enhances macrophage inflammatory protein-1beta mRNA expression through protein kinase C-delta and NADPH oxidase in macrophage-like differentiated U937 cells. Biochim Biophys Acta 2008;1780:307–314.
   PubMed Web of Science ®Google Scholar
• Monjo M, Rubert M, Ellingsen JE, . Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells. Cell Physiol Biochem 2010;26:647–656.
   PubMed Web of Science ®Google Scholar
• Park JB, Zhang H, Lin CY, . Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α. J Surg Res 2011 Jan 15. [Epub ahead of print]
   Google Scholar
• Zhang HW, Yang Y, Zhang K, . Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCdelta phosphorylation. Eur J Pharmacol 2008;591:7–12.
   PubMed Web of Science ®Google Scholar
• Junttila I, Bourette RP, Rohrschneider LR, . M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-delta and expression of Pkare. J Leukoc Biol 2003;73:281–288.
   PubMed Web of Science ®Google Scholar
• Owen-Lynch PJ, Czaplewski LG, Hunter MG, . The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemias. Leuk Lymphoma 1998;30: 41–53.
   PubMed Web of Science ®Google Scholar
• Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004;36:1882–1886.
   PubMed Web of Science ®Google Scholar
• Keyomarsi K, Sandoval L, Band V, . Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 1991;51:3602–3609.
   PubMed Web of Science ®Google Scholar
• Wu J, Wong WW, Khosravi F, . Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Res 2004;64:6461–6468.
   PubMed Web of Science ®Google Scholar
• Dai Y, Khanna P, Chen S, . Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation. Blood 2007;109:4415–4423.
   PubMed Web of Science ®Google Scholar
• van de Donk NW, Kamphuis MM, van Kessel B, . Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood 2003;102:3354–3362.
   PubMed Web of Science ®Google Scholar